US panel recommends approval for BAK1:
This article was originally published in Clinica
The US FDA Orthopaedic and Rehabilitation Devices Advisory Panel has recommended approval for Spine-Tech's BAK1 interbody fusion system. Approval is subject to post-marketing surveillance and labelling.
You may also be interested in...
Companion diagnostics are needed increasingly by pharma companies to justify the safety and effectiveness of their products. With specific first-time EU regulation of these products within sight – and urgently needed – is there a risk of delays to these products being able to demonstrate compliance?
Draft policy moots crowdfunding for high-cost rare diseases alongside financial support for those "amenable to one-time treatment" but falls way short of some patient groups' expectations.
India’s Hilleman Laboratories says it’s aiming to develop an affordable vaccine that will target pregnant women in low- and middle-income countries to prevent Group B Streptococcus, a potentially fatal infection passed to babies during childbirth.